
Axial


Find Us in Dublin and New York
Europe & United States Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics From seed to public offerings Potential for a strong exit within 4 to 6 years Three funds; €301M under management; investments of €10M to €15M Committed to investing responsibly Read our Responsible Investment Policy here Will lead or co-lead an investment syndicate
If you are an entrepreneur with an ambitious plan, use the button below to say hello
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Fountain Healthcare Partners.
Similar listings buyers compare against this one.

Axial

Ignite Accelerator

Zoovu

AIM Group

SOSV

500 Global
Everything here links back to the same verified catalogue. Pick your next stop.